Harvard Apparatus Regenerative Technology (HRGN)
OTHER OTC:HRGN
Want to see HRGN full AI Analyst Report?
Total Valuation
Harvard Apparatus Regenerative Technology has a market cap or net worth of $20.92M. The enterprise value is $20.68M.
Market Cap$20.92M
Enterprise Value$20.68M
Share Statistics
Harvard Apparatus Regenerative Technology has 17,580,744 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding17,580,744
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Harvard Apparatus Regenerative Technology’s return on equity (ROE) is -6.50 and return on invested capital (ROIC) is -606.61%.
Return on Equity (ROE)-6.50
Return on Assets (ROA)-2.57
Return on Invested Capital (ROIC)-606.61%
Return on Capital Employed (ROCE)-6.67
Revenue Per Employee88.00K
Profits Per Employee-858.63K
Employee Count8
Asset Turnover0.26
Inventory Turnover40.38
Valuation Ratios
The current PE Ratio of Harvard Apparatus Regenerative Technology is ―. Harvard Apparatus Regenerative Technology’s PEG ratio is 0.23.
PE Ratio―
PS Ratio43.17
PB Ratio28.75
Price to Fair Value28.75
Price to FCF-7.94
Price to Operating Cash Flow-4.91
PEG Ratio0.23
Income Statement
In the last 12 months, Harvard Apparatus Regenerative Technology had revenue of 704.00K and earned -6.87M in profits. Earnings per share was -0.42.
Revenue704.00K
Gross Profit58.00K
Operating Income-7.62M
Pretax Income-6.87M
Net Income-6.87M
EBITDA-6.76M
Earnings Per Share (EPS)-0.42
Cash Flow
In the last 12 months, operating cash flow was -4.01M and capital expenditures 0.00, giving a free cash flow of -4.01M billion.
Operating Cash Flow-4.01M
Free Cash Flow-4.01M
Free Cash Flow per Share-0.23
Dividends & Yields
Harvard Apparatus Regenerative Technology pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta-0.16
52-Week Price Change-32.53%
50-Day Moving Average1.54
200-Day Moving Average1.74
Relative Strength Index (RSI)24.02
Average Volume (3m)1.13K
Important Dates
Harvard Apparatus Regenerative Technology upcoming earnings date is May 18, 2026, Before Open (Confirmed).
Last Earnings DateAug 19, 2025
Next Earnings DateMay 18, 2026
Ex-Dividend Date―
Financial Position
Harvard Apparatus Regenerative Technology as a current ratio of 1.19, with Debt / Equity ratio of 188.04%
Current Ratio1.19
Quick Ratio1.18
Debt to Market Cap<0.01
Net Debt to EBITDA0.17
Interest Coverage Ratio-952.38
Taxes
In the past 12 months, Harvard Apparatus Regenerative Technology has paid 0.00 in taxes.
Income Tax0.00
Effective Tax Rate0.00
Enterprise Valuation
Harvard Apparatus Regenerative Technology EV to EBITDA ratio is -4.33, with an EV/FCF ratio of -7.64.
EV to Sales41.53
EV to EBITDA-4.33
EV to Free Cash Flow-7.64
EV to Operating Cash Flow-7.64
Balance Sheet
Harvard Apparatus Regenerative Technology has $419.00K in cash and marketable securities with $173.00K in debt, giving a net cash position of $246.00K billion.
Cash & Marketable Securities$419.00K
Total Debt$173.00K
Net Cash$246.00K
Net Cash Per Share$0.01
Tangible Book Value Per Share$0.06
Margins
Gross margin is -170.78%, with operating margin of -1082.24%, and net profit margin of -975.71%.
Gross Margin-170.78%
Operating Margin-1082.24%
Pretax Margin-975.71%
Net Profit Margin-975.71%
EBITDA Margin-959.94%
EBIT Margin-974.57%
Analyst Forecast
The average price target for Harvard Apparatus Regenerative Technology is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast111.72%
EPS Growth Forecast17.33%